Skip to main content
. 2021 Nov 30;13:325–332. doi: 10.2147/OARRR.S339134

Table 3.

Shows the Distribution of Duration of the Disease Among the Study Participants According to RA Serotypes

SPRA (37) SNRA (23) Total
NO % NO %
Duration of the disease <1 year 9 24.3% 11 47.8% 20
1–5 years 15 40.5% 9 39.1% 24
>5 years 13 35.1% 3 13% 16